Invesco Ltd. lifted its holdings in shares of TrueBlue, Inc. (NYSE:TBI - Free Report) by 2.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,080,030 shares of the business services provider's stock after purchasing an additional 47,089 shares during the quarter. Invesco Ltd. owned approximately 6.97% of TrueBlue worth $11,045,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of TBI. Nuveen Asset Management LLC increased its stake in shares of TrueBlue by 262.7% during the 4th quarter. Nuveen Asset Management LLC now owns 561,093 shares of the business services provider's stock worth $4,713,000 after purchasing an additional 406,405 shares during the last quarter. Royce & Associates LP grew its stake in TrueBlue by 23.5% in the 1st quarter. Royce & Associates LP now owns 1,880,732 shares of the business services provider's stock valued at $9,987,000 after buying an additional 357,539 shares during the last quarter. Peapod Lane Capital LLC acquired a new position in TrueBlue in the 1st quarter valued at $1,385,000. GSA Capital Partners LLP grew its stake in TrueBlue by 527.3% in the 1st quarter. GSA Capital Partners LLP now owns 287,625 shares of the business services provider's stock valued at $1,527,000 after buying an additional 241,777 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in TrueBlue by 46.3% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 613,852 shares of the business services provider's stock valued at $3,260,000 after buying an additional 194,155 shares during the last quarter. Institutional investors and hedge funds own 97.15% of the company's stock.
TrueBlue Price Performance
NYSE:TBI traded down $0.16 during mid-day trading on Friday, hitting $5.98. The company's stock had a trading volume of 104,499 shares, compared to its average volume of 184,829. TrueBlue, Inc. has a fifty-two week low of $3.45 and a fifty-two week high of $9.05. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $178.65 million, a price-to-earnings ratio of -5.20 and a beta of 1.55. The stock has a fifty day moving average of $6.48 and a 200-day moving average of $5.88.
TrueBlue (NYSE:TBI - Get Free Report) last announced its earnings results on Monday, August 4th. The business services provider reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.31) by $0.24. TrueBlue had a negative net margin of 2.21% and a negative return on equity of 5.74%. The company had revenue of $396.30 million during the quarter, compared to the consensus estimate of $400.52 million. TrueBlue has set its Q3 2025 guidance at EPS. As a group, equities analysts forecast that TrueBlue, Inc. will post 0.15 EPS for the current fiscal year.
Analyst Ratings Changes
Separately, BMO Capital Markets raised their target price on shares of TrueBlue from $7.00 to $8.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $8.00.
Get Our Latest Stock Analysis on TrueBlue
TrueBlue Company Profile
(
Free Report)
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Further Reading

Before you consider TrueBlue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.
While TrueBlue currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.